← Back to Clinical Trials
Recruiting NCT06774339
Biomarkers and Inflammation in Solid Organ Transplantation: Relationship With Short- and Long-Term Outcomes
Trial Parameters
Condition Solid Organ Transplantation
Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Study Type OBSERVATIONAL
Phase N/A
Enrollment 250
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-10-10
Completion 2031-12
Brief Summary
This is a prospective, tissue-based, low-risk, non-pharmacological study that will include adult patients undergoing solid organ transplantation (heart, liver, lung, kidney) followed at the following Units of the IRCCS Azienda Ospedaliero-Universitaria di Bologna (IRCCS AOUBO): * Heart Failure and Transplants (heart-lung) * Internal Medicine for the Treatment of Severe Organ Failures (liver) * Nephrology, Dialysis, and Transplantation (kidney).
Eligibility Criteria
Inclusion Criteria: * Adult patients (≥ 18 years old at the time of enrollment) who have undergone at least one of the following: Liver transplant, Kidney transplant, Heart transplant, Lung transplant during the study period. * Informed consent acquisition. Exclusion Criteria: * none
Related Trials
NCT06774339
Biomarkers and Inflammation in Solid Organ Transplantation: Relationship With Short- and Long-Term O
View Trial →
NCT07291258
Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines
View Trial →
NCT01163578
Biomarkers in Transplant Recipients to Improve Outcomes
View Trial →